Testing effectiveness (Phase 2)Study completedNCT02027935
What this trial is testing
CD8+ Antigen-Specific T Cells, Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Melanoma
Who this might be right for
Metastatic MelanomaStage IV Cutaneous Melanoma AJCC v6 and v7
M.D. Anderson Cancer Center 16